產品資訊 - 5%/10%/50% Glucose Intravenous Infusion->glucose

登入

加入會員

求助

Shijiazhuang No.4 Pharmaceutical Co., Ltd.

	Recommended Results

5%/10%/50% Glucose Intravenous Infusion

產品分類 :

化學->藥品->葡萄糖

產品規格

Model No:	Z02102

Country	CN
Brand	SHIMEN
Materials	Glucose Water for Injection
Size	5g/100ml,12.5g/250ml,25g/500ml
Color	Clear liquid
Packing	100ml: 60bottle/carton 500ml: 30bottle/carton
Minimum Order	10000 unit
Payment Term	TT/LC

產品描述

5% GLUCOSE INJECTION
5% Glucose Injection is a sterile, nonpyrogenic solution for fluid replenishment and caloric supply in single dose.

Product Name: Dextrose Injection 5% ,Glucose Injection 5%,Dextrose infusion 5%,Glucose infusion 5%

Product Description : A clear, colourless or almost colourless liquid,taste sweet.

Strength: 5g/100ml,12.5g/250ml,25g/500ml

INN or Generic Name: Hydrous Dextrose
Pharmaceutical Dosage Form: injection

Port: Any port (depends on requests) Certificate:GMP
Exporting Region: Areas which GMP is applicable

Therapeutic indications
Intravenous solutions containing Dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.

Posology and method of administration
The dose is dependent upon the age, weight and clinical condition of the patient.

As reported in the literature, the dosage and constant infusion rate of intravenous Dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.

Drug Interactions

Additives may be incompatible. Consult with pharmacist, if available. When introducing additives, use aseptic technique, mix thoroughly and do not store.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

Contraindications:

5% Dextrose Injection, USP without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Special warning and precautions for use:

Warnings
Excessive administration of potassium-free solutions may result in significant hypokalemia.
The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.
The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.
Precautions
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Solutions containing Dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.

Do not administer unless solution is clear and container is undamaged. Discard unused portion.

Carcinogenesis, Mutagenesis, Impairment of Fertility:
Studies with 5% Dextrose Injection, USP have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.

Interaction with other medicinal products and other forms of Interactions